You just read:

Imprimis Announces Multi-Center Clinical Trial for Dropless® TriMoxi™ (Triamcinolone Acetonide-Moxifloxacin for injection) Formulation in Canada

News provided by

Imprimis Pharmaceuticals, Inc.

Aug 01, 2018, 07:30 ET